Kinetics of antiviral activity by human immunodeficiency virus type 1- specific cytotoxic T lymphocytes (CTL) and rapid selection of CTL escape virus in vitro

Journal of Virology

Volumn 72, Issue 8, 1998, Pages 6851-6857

  Van Baalen, C A ^a   Schutten, M ^a   Huisman, R C ^a   Boers, P H M ^a   Gruters, R A ^a,b   Osterhaus, A D M E ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; EPITOPE; HLA B ANTIGEN; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; COCULTURE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS REPLICATION;

EID: 0031903089     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.8.6851-6857.1998     Document Type: Article

References (33)

1. Bloom, B. R. 1996. A perspective on AIDS vaccines. Science 272:1888-1890.
2. Borrow, P., H. Lewicki, X. Wei, M. S. Horwitz, N. Peffer, H. Meyers, J. A. Nelson, J. E. Gairin, B. H. Hahn, M. B. A. Oldstone, and G. M. Shaw. 1997. Antiviral pressure exerted by HIV-1-specitic cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 3:205-211.
3. + cells. Virology 225:248-253.
4. Collins, K. L., B. K. Chen, S. A. Kalams, B. D. Walker, and D. Baltimore. 1998. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391:397-401.
5. DiBrino, M., K. C. Parker, D. H. Margulies, J. Shiloach, R. V. Turner, W. E. Biddison, and J. E. Coligan. 1994. The HLA-B14 peptide binding site can accommodate peptides with different combinations of anchor peptides. J. Biol. Chem. 269:32426-32434.
6. Finzi, D., M. Hermankova, T. Pierson, L. Carruth, C. Buck, R. E. Chaisson, T. C. Quinn, K. Chadwick, J. Margolick, R. Brookmeyer, J. Gallant, M. Markowitz, D. D. Ho, D. D. Richman, and R. F. Siliciano. 1997. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278:1295-1300.
7. + T-cell immunity to murine rotavirus in the absence of perforine, Fas and gamma interteron. J. Virol. 71:479-186.
8. Gotch, F. M., R. A. Koup, and J. T. Safrit. 1997. New observations on cellular immunoresponses to HIV and T-cell epitopev. AIDS 11:S99-S107.
9. Goulder, P. J. R., R. E. Phillips, R. A. Colbert, S. McAdam, G. Ogg, M. Nowak, P. Giangrande, G. Luzzi, B. Morgan, A. Edwards, A. J. McMichael, and S. Rowland-Jones. 1997. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. 3:212-217.
10. Gregersen, J. P., H. Wege, L. Preiss, and K. D. Jentsch. 1988. Detection of human immunodeficiency virus and other retroviruses in cell culture supernatants by a reverse transcriptase microassay. J. Virol. Methods 19:161-168.
11. Guidotti, L. G., K. Ando, M. V. Hobbs, T. Ishikawa, L. Runkel, R. D. Schreiber, and F. V. Chisari. 1994. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc. Natl. Acad. Sci. USA 91:3764-3768.
12. Kagi, D., B. Ledermann, K. Burki, R. M. Zinkernagel, and H. Hengartner. 1996. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14:207-232.
13. Kerkau, T., R. Schmitt Landgraf, A. Schimpl, and E. Wecker. 1989. Down-regulation of HLA class I antigens in HIV-1-infected cells. Aids Res. Hum. Retroviruses 5:613-620.
14. Kim, S., R. Byrn, J. Groopman, and D. Baltimore. 1989. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression. J. Virol. 63:3708-3713.
15. Kingsman, S. M., and A. J. Kingsman. 1996. The regulation of human immunodeficiency virus type-1 gene expression. Eur. J. Biochem. 240:491-507.
16. + T cells. Immunol. Today 17:217-224.
17. Maciaszek, J. W., N. A. Parada, W. W. Cruikshank, D. M. Center, H. Kornfeld, and G. A. Viglianty. 1997. IL-16 represses HIV-1 promoter activity. J. Immunol. 158:5-8.
18. McCune, J. M. 1995. Viral latency in HIV disease. Cell 82:183-188.
19. Meyers, G., B. Foley, J. W. Mellors, B. Korber, K. Jeang, and S. Wain-Hobson. 1997. Human retroviruses and AIDS 1996: a compilation and analysis of nucleic acid and amino acid sequences. Los Alamos National Laboratory, Los Alamos, N.Mex.
20. Pantaleo, G. 1997. How immune-based interventions can change HIV therapy. Nat. Med. 3:483-486.
21. Perelson, A. S., A. U. Neumann, M. Markowitz, J. M. Leonard, and D. D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-pan, and viral generation time. Science 271:1582-1586.
22. Ranki, A., A. Lagerstedt, V. Ovod, E. Aavik, and K. J. Krohn. 1994. Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines. Arch. Virol. 139:365-378.
23. Scheppler, J. A., J. K. A. Nicholson, D. C. Swan, A. Ahmed-Ansari, and J. S. McDougal. 1989. Down-modulation of MHC-I in CD4+ T cell line CEM-E5, after HIV-1 infection. J. Immunol. 143:2858-2866.
24. Seeger, M., K. Ferrell, R. Franck, and W. Dubiel. 1997. HIV-1 Tat inhibits the 20 S proteasome and its 11 S regulator-mediated activation. J. Biol. Chem. 272:8145-8148.
25. Siebelink, K. H., I. H. Chu, G. F. Rimmelzwaan, K. Weijer, A. D. Osterhaus, and M. L. Bosch. 1992. Isolation and partial characterization of infectious molecular clones of feline immunodeficiency virus obtained directly from bone marrow of DNA of a naturally infected cat. J. Virol. 66:1091-1097.
26. Tsomides, T. J., A. Aldovini, R. P. Johnson, B. D. Walker, R. A. Young, and H. N. Eisen. 1994. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J. Exp. Med. 180:1283-1293.
27. Tsubota, H., C. I. Lord, D. I. Watkins, C. Morimoto, and N. L. Letvin. 1989. A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. J. Exp. Med. 169:1421-1434.
28. van Baalen, C. A., O. Pontesilli, R. C. Huisman, A. M. Geretti, M. R. Klein, F. De Wolf, F. Miedema, R. A. Gruters, and A. D. M. E. Osterhaus. 1997. Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS. J. Gen. Virol. 78:1913-1918.
29. Van der Burg, S. H., M. R. Klein, O. Pontesilli, A. M. Holwerda, J. W. Drijfhout, W. M. Kast, F. Miedema, and C. J. M. Melief. 1997. HIV-1 reverse transcriptase-specific CTL against conserved epitopes do not protect against progression to AIDS. J. Immunol. 159:3648-3654.
30. Wong, J. K., M. Hezareh, H. F. Günthard, D. V. Havlir, C. C. Ignacio, C. A. Spina, and D. D. Richman. 1997. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278:1291-1295.
31. Yang, O. O., S. A. Kalams, M. Rosenzweig, A. Trocha, N. Jones, M. Koziel, B. D. Walker, and R. P. Johnson. 1996. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes. J. Virol. 70: 5799-5806.
32. + cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolylic mechanisms. J. Virol. 71:3120-3128.
33. + cells transtected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression. Nat. Med. 3:659-664.